234 related articles for article (PubMed ID: 7378252)
1. Pharmacokinetics of a sustained-release theophylline formulation.
Trembath PW; Boobois SW
Br J Clin Pharmacol; 1980 Apr; 9(4):365-9. PubMed ID: 7378252
[TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of theophylline in humans.
Raz I; Bialer M; Salame K; Bar-On H
Eur J Clin Pharmacol; 1984; 26(3):401-3. PubMed ID: 6734702
[TBL] [Abstract][Full Text] [Related]
3. Comparative bio-availability of theophylline whole and halved sustained-release tablets.
Müller FO; Hundt HK; Luus HG; van Dyk M; Groenewoud G; van der Meer MJ; Steinijans VW
S Afr Med J; 1987 Aug; 72(3):175-8. PubMed ID: 3299763
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
5. The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets.
Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Thürkow-Luikens AJ
Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):506-10. PubMed ID: 6500770
[TBL] [Abstract][Full Text] [Related]
6. Comparative bioavailability of sustained-release and conventional tablets of hydroxyethyltheophylline in man.
Sharma PL; Sharma RM
Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):394-6. PubMed ID: 583044
[TBL] [Abstract][Full Text] [Related]
7. Chronopharmacokinetics of theophylline after sustained release and intravenous administration to adults.
Jonkman JH; van der Boon WJ; Balant LP; Schoenmaker R; Holtkamp A
Eur J Clin Pharmacol; 1984; 26(2):215-22. PubMed ID: 6723760
[TBL] [Abstract][Full Text] [Related]
8. Plasma theophylline levels after sustained-release aminophylline.
Trembath PW; Boobis SW
Clin Pharmacol Ther; 1979 Nov; 26(5):654-9. PubMed ID: 498707
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic properties of a new sustained-release theophylline preparation.
Dahlqvist R; Billing B
Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927
[TBL] [Abstract][Full Text] [Related]
10. Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II.
Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I
Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):196-201. PubMed ID: 3710632
[TBL] [Abstract][Full Text] [Related]
11. Effect of food on the bioavailability and pattern of release of a sustained-release theophylline tablet.
Leeds NH; Gal P; Purohit AA; Walter JB
J Clin Pharmacol; 1982 Apr; 22(4):196-200. PubMed ID: 7096605
[TBL] [Abstract][Full Text] [Related]
12. Absorption kinetics and steady-state plasma concentrations of theophylline following therapeutic doses of two sustained-release preparations.
Andersen O; Nielsen MK; Eriksen PB; Fenger M; Knudsen PJ
J Pharm Sci; 1983 Feb; 72(2):158-61. PubMed ID: 6834254
[TBL] [Abstract][Full Text] [Related]
13. Studies on the pharmacokinetics of theophylline in asthmatic patients following multiple oral dosing of a sustained-release theophylline tablet formulation.
Takagi K; Yamaki K; Satake T; Hasegawa T; Ogura Y; Suzuki R; Mizukami Y
Arerugi; 1985 Nov; 34(11):1006-14. PubMed ID: 4084062
[No Abstract] [Full Text] [Related]
14. Effect of food on bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms: Part I.
Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I
Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):148-52. PubMed ID: 3699941
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
Valet SB; Schwartz RH; Brooks JG
Ann Allergy; 1983 Mar; 50(3):161-5. PubMed ID: 6829982
[TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetics of theophylline and ethylenediamine following single and repeated doses of a sustained-release aminophylline preparation to volunteers.
Cotgreave IA; Caldwell J
J Pharm Pharmacol; 1985 Sep; 37(9):618-21. PubMed ID: 2867181
[TBL] [Abstract][Full Text] [Related]
17. Comparative absorption of theophylline following multiple doses of a sustained-release formulation and an elixir in humans.
Harrison LI; French IW; Mildon CA
Clin Ther; 1982; 4(6):489-96. PubMed ID: 7093982
[TBL] [Abstract][Full Text] [Related]
18. The relation of product formulation to absorption of oral theophylline.
Weinberger M; Hendeles L; Bighley L
N Engl J Med; 1978 Oct; 299(16):852-7. PubMed ID: 692577
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.
Horai Y; Ishizaki T; Sasaki T; Chiba K; Suganuma T; Echizen H; Ohnishi A
Eur J Clin Pharmacol; 1983; 24(1):79-87. PubMed ID: 6832206
[TBL] [Abstract][Full Text] [Related]
20. Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease.
Taylor DR; Duffin D; Kinney CD; McDevitt DG
Br J Clin Pharmacol; 1984 Jul; 18(1):27-30. PubMed ID: 6743488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
